Dezhi Kang Selected Research

Neoplasms (Cancer)

4/2024	Carrier-Free Self-Assembly Nano-Sonosensitizers for Sonodynamic-Amplified Cuproptosis-Ferroptosis in Glioblastoma Therapy.
12/2022	Single-cell RNA sequencing reveals intra-tumoral heterogeneity of glioblastoma and a pro-tumor subset of tumor-associated macrophages characterized by EZH2 overexpression.
1/2022	Glioblastoma vaccine tumor therapy research progress.
1/2022	Retraction notice to "Exosome-mediated transfer of circRNA CircNFIX enhances temozolomide resistance in glioma" [Cancer Lett. 479 (2020) 1-12].
1/2022	CBX4-dependent regulation of HDAC3 nuclear translocation reduces Bmp2-induced osteoblastic differentiation and calcification in adamantinomatous craniopharyngioma.
1/2022	Biomineralized hybrid nanodots for tumor therapy via NIR-II fluorescence and photothermal imaging.
1/2021	NPC2 as a Prognostic Biomarker for Glioblastoma Based on Integrated Bioinformatics Analysis and Cytological Experiments.
1/2020	Exosome-mediated transfer of circRNA CircNFIX enhances temozolomide resistance in glioma.
10/2019	Quantitative assessment of microenvironment characteristics and metabolic activity in glioma via multiphoton microscopy.
1/2019	Automatic and label-free identification of blood vessels in gliomas using the combination of multiphoton microscopy and image analysis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dezhi Kang Research Topics

Disease

12	Neoplasms (Cancer) 04/2024 - 01/2012
12	Glioma (Gliomas) 07/2022 - 11/2012
10	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 08/2023 - 01/2017
7	Glioblastoma (Glioblastoma Multiforme) 04/2024 - 01/2012
7	Brain Injuries (Brain Injury) 01/2023 - 04/2015
6	Aneurysm (Aneurysms) 02/2024 - 01/2006
6	Cerebral Hemorrhage 01/2024 - 04/2015
4	Brain Edema (Cerebral Edema) 08/2023 - 01/2006
4	Hydrocephalus (Hydrocephaly) 06/2022 - 08/2013
4	Brain Ischemia (Cerebral Ischemia) 01/2021 - 08/2018
3	Meningioma (Meningiomas) 07/2023 - 01/2020
3	Intracranial Aneurysm (Cerebral Aneurysm) 06/2022 - 01/2006
3	Rupture 06/2022 - 10/2017
3	Epilepsy (Aura) 01/2022 - 09/2017
3	Acne Vulgaris 12/2016 - 06/2015
2	Inflammation (Inflammations) 01/2024 - 06/2015
2	Edema (Dropsy) 08/2023 - 11/2012
2	Neuroinflammatory Diseases 01/2023 - 01/2017
2	Infections 01/2021 - 08/2013
2	Brain Neoplasms (Brain Tumor) 06/2016 - 01/2012
1	Central Nervous System Diseases (CNS Diseases) 01/2024
1	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2023
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 08/2023
1	Brain Hypoxia (Cerebral Hypoxia) 06/2022
1	Seizures (Absence Seizure) 01/2022
1	Hemorrhage 01/2022
1	Pneumonia (Pneumonitis) 01/2021
1	Cerebral Infarction 01/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Infarction (Infarctions) 01/2021
1	von Hippel-Lindau Disease (von Hippel Lindau Disease) 01/2020
1	Hypernatremia 01/2020
1	Adenoma (Adenomas) 01/2020
1	Acromegaly 01/2020
1	Pituitary Neoplasms (Pituitary Adenoma) 01/2020
1	Acidosis 01/2020
1	Proteinuria 01/2020
1	Parkinsonian Disorders (Parkinsonism) 12/2019
1	Parkinson Disease (Parkinson's Disease) 12/2019

Drug/Important Bio-Agent (IBA)

8	Biomarkers (Surrogate Marker)IBA 06/2022 - 01/2012
5	Circular RNAIBA 07/2022 - 12/2019
3	Temozolomide (Temodar)FDA LinkGeneric 01/2022 - 01/2020
3	NeuroglobinIBA 01/2020 - 01/2018
3	Nucleotide AptamersIBA 05/2018 - 01/2012
2	CollagenIBA 07/2023 - 01/2019
2	Neuroprotective AgentsIBA 01/2023 - 01/2017
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 06/2022 - 01/2021
2	Phosphates (Orthophosphate)IBA 06/2022 - 01/2021
2	Fibrinogen (Factor I)FDA Link 04/2020 - 01/2020
2	NFI Transcription FactorsIBA 01/2020 - 12/2019
2	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 08/2018 - 10/2017
2	necrostatin-1IBA 01/2017 - 04/2015
2	PorphyrinsIBA 01/2016 - 06/2015
2	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 01/2016 - 06/2015
1	IonsIBA 04/2024
1	IonophoresIBA 04/2024
1	N,N- diethyl- 2- (2- (4- (2- fluoroethoxy)phenyl)- 5,7- dimethylpyrazolo(1,5- a)pyrimidin- 3- yl)acetamideIBA 01/2024
1	COVID-19 VaccinesIBA 12/2023
1	IronIBA 08/2023
1	ferrostatin-1IBA 01/2023
1	Phospholipases A2 (Phospholipase A2)IBA 01/2023
1	RNA (Ribonucleic Acid)IBA 12/2022
1	VaccinesIBA 01/2022
1	Cancer VaccinesIBA 01/2022
1	Protein Subunit VaccinesIBA 01/2022
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2022
1	Histone Acetyltransferases (Histone Acetyltransferase)IBA 01/2022
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2022
1	Histones (Histone)IBA 01/2022
1	EnzymesIBA 01/2022
1	Hydroxyl RadicalIBA 01/2022
1	MicroRNAs (MicroRNA)IBA 05/2021
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2021
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2021
1	TeaIBA 01/2021
1	CalciumIBA 01/2021
1	Hemoglobins (Hemoglobin)IBA 01/2021
1	Circulating Tumor DNAIBA 08/2020
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2020
1	Colloids (Colloid)IBA 01/2020
1	Insulin (Novolin)FDA Link 01/2020
1	Long Noncoding RNAIBA 01/2020
1	Growth Hormone (Somatotropin)IBA 01/2020
1	DiureticsIBA 01/2020
1	Levodopa (L Dopa)FDA LinkGeneric 12/2019
1	NAD (NADH)IBA 10/2019

Therapy/Procedure

13	Therapeutics 04/2024 - 01/2012
3	Minimally Invasive Surgical Procedures 04/2023 - 01/2021
2	Surgical Instruments (Clip) 02/2024 - 01/2006
2	Drug Therapy (Chemotherapy) 03/2021 - 01/2020
1	Laminectomy 04/2022
1	Immunotherapy 01/2022
1	Emergency Treatment 01/2022
1	Lasers (Laser) 01/2022
1	Perioperative Period 01/2022
1	Aftercare (After-Treatment) 01/2021
1	Treatment Delay 01/2021
1	Ventriculoperitoneal Shunt 01/2020
1	Activities of Daily Living (ADL) 12/2019
1	Deep Brain Stimulation 12/2019